London based Laverock Therapeutics shows BiotechTV the new space it moved into in LBIC's Apex Building in Kings Cross where it will be doing its work on programmable gene silencing

Apr 29, 2025
1 min read

CEO David Venables describes Laverock's platform that repurposed miRNA to reprogram cells in a highly specific way. It's own lead programs will be in oncology and regenerative medicine.

https://vimeo.com/1079840017

Recent Posts

See All

Curve Biosciences is creating a DNA based blood test to detect and measure chronic illness throughout the body - the first programs will focus on liver disease

From Germany: InnovationLab in Heidelberg aims to spur collaboration between science and industry. It offers entrepreneurs help with labs space, tech transfer, and incubation

From Germany: Heidelberg University has created a unique platform, hei_INNOVATION, that is meant to encourage its students to become entrepreneurs and then help them achieve their goals along the way

London based Laverock Therapeutics shows BiotechTV the new space it moved into in LBIC's Apex Building in Kings Cross where it will be doing its work on programmable gene silencing

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight